Literature DB >> 25478832

Structures of an Eph receptor tyrosine kinase and its potential activation mechanism.

Qiang Wei1, Jun Liu2, Nan Wang1, Xiaoying Zhang1, Jin Jin1, Ian Chin-Sang2, Jimin Zheng1, Zongchao Jia3.   

Abstract

Eph receptor tyrosine kinases (RTKs) and their ephrin ligands play a crucial role in both physiological and pathophysiological processes, including tumourigenesis. A previous study of Eph RTKs established a regulatory role for the juxtamembrane segment (JMS) in kinase activation through the phosphorylation of two tyrosines within the JMS. Here, structures of EphA2 representing various activation states are presented. By determining the unphosphorylated inactive and phosphorylated active structures as well as an alternative conformation, conformational changes during kinase activation have been revealed. It is shown that phosphorylation of a tyrosine residue (Tyr772) in the activation loop without direct involvement of the JMS is sufficient to activate the EphA2 kinase. This mechanistic finding is in contrast to the mechanism of other Eph RTKs, such as EphB2, in which phosphorylation of the two JMS tyrosines initiates the dissociation of the JMS and triggers activation-loop phosphorylation for kinase activation. Furthermore, experiments demonstrate that the EphA2 substrate PTEN, a phosphatase that has been implicated in tumour suppression, acts to regulate the phosphorylation states of EphA2, exemplifying a unique reciprocal enzyme-substrate system. Based on these studies, it is therefore suggested that EphA2 may possess an alternate activation mechanism distinct from other Eph RTKs.

Entities:  

Keywords:  Eph receptor tyrosine kinases; EphA2; PTEN; kinase activation; reciprocal enzyme–substrate system

Mesh:

Substances:

Year:  2014        PMID: 25478832     DOI: 10.1107/S1399004714021944

Source DB:  PubMed          Journal:  Acta Crystallogr D Biol Crystallogr        ISSN: 0907-4449


  5 in total

1.  Identifying three-dimensional structures of autophosphorylation complexes in crystals of protein kinases.

Authors:  Qifang Xu; Kimberly L Malecka; Lauren Fink; E Joseph Jordan; Erin Duffy; Samuel Kolander; Jeffrey R Peterson; Roland L Dunbrack
Journal:  Sci Signal       Date:  2015-12-01       Impact factor: 8.192

2.  EPHA2, EPHA4, and EPHA6 Expression in Uveal Melanomas: Searching for the Culprits of Neoplasia.

Authors:  Alexandros Pergaris; Eugene Danas; Pawel Gajdzis; Georgia Levidou; Malgorzata Gajdzis; Nathalie Cassoux; Sophie Gardrat; Piotr Donizy; Penelope Korkolopoulou; Nikolaos Kavantzas; Jerzy Klijanienko; Stamatios Theocharis
Journal:  Diagnostics (Basel)       Date:  2022-04-19

3.  A new autoinhibited kinase conformation reveals a salt-bridge switch in kinase activation.

Authors:  Qiang Wei; Shaoyuan Yang; Dan Li; Xiaoying Zhang; Jimin Zheng; Zongchao Jia
Journal:  Sci Rep       Date:  2016-06-21       Impact factor: 4.379

Review 4.  Utilizing Exosomal-EPHs/Ephrins as Biomarkers and as a Potential Platform for Targeted Delivery of Therapeutic Exosomes.

Authors:  Dimitrios Goutas; Alexandros Pergaris; Nikolaos Goutas; Stamatios Theocharis
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 5.  The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management.

Authors:  Iason Psilopatis; Alexandros Pergaris; Kleio Vrettou; Gerasimos Tsourouflis; Stamatios Theocharis
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.